510(k) · Cleared
ClearedIconic Blue Nitrile Glove - Tested for use with Chemotherapy Drugs & Fentanyl Citrate
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Iconic Medicare Sdn Bhd · LZA Polymer Patient Examination Glove
Cleared on Jan 11, 2023 as substantially equivalent to K221269 (Better Care Plastic Technology Co., Ltd., 2022) after a 173-day review. Its family tree reaches back 3 generations to 2019.
- Decided
- Jan 11, 2023
- Review
- 173 days
- Class
- Class I
- Product code
- LZA
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 3 generations to K183287 (2019). No later device cites it as a predicate yet.
- Root · 3 generations backK183287 Powder Free Nitrile Patient Examination Glove, Blue Colored…Kossan International Sdn Bhd · 2019
- 2 generations backK192954 Power Free Nitrile Examination Gloves Tested for Use with…Comfort Rubber Gloves Industries Sdn. Bhd. · 2020
- 1 generation backK221269 Powder Free Nitrile Examination Gloves (Blue),Tested for Use with…Better Care Plastic Technology Co., Ltd. · 2022
- This deviceK222181 Iconic Blue Nitrile Glove - Tested for use with Chemotherapy Drugs &…Iconic Medicare Sdn Bhd · 2023
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K183287 | Powder Free Nitrile Patient Examination Glove, Blue Colored, Non-Sterile… | Kossan International Sdn Bhd | 2019 | — |
| −2 | K192954 | Power Free Nitrile Examination Gloves Tested for Use with Chemotherapy Drugs… | Comfort Rubber Gloves Industries Sdn. Bhd. | 2020 | — |
| −1 | K221269 | Powder Free Nitrile Examination Gloves (Blue),Tested for Use with Chemotherapy… | Better Care Plastic Technology Co., Ltd. | 2022 | — |
| 0 (this device) | K222181 | Iconic Blue Nitrile Glove - Tested for use with Chemotherapy Drugs & Fentanyl… | Iconic Medicare Sdn Bhd | 2023 | — |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LZA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LZA device
- #1 K192333 Blue Nitrile Examination Gloves Powder Freescore 71.0 · 2 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K221269 | Powder Free Nitrile Examination Gloves (Blue),Tested for Use with Chemotherapy Drugs and… Cleared while this submission was under review Summary page 5…Email: [email protected] 4. Identification of the Legally Marketed Predicate Device: Predicate Device: Better Care Plastic Technology Co., Ltd. 510k Number: - K221269 Device Name: Powder Free Nitrile Examination Gloves (Blue), Tested for Use with Chemotherapy Drugs and Fentanyl Citrate… | 2022 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 4 years and passes through 4 companies; a new generation was cleared every 1.2 years on median.
- None of the 3 ancestors has a recall.
- 3 other devices also cite its predicate K221269.
How does its category compare?
All LZA devicesLZA Polymer Patient Examination Glove: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.
FDA decisions per year · LZA
24in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LZA
110in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LZA
3so far in 2026, the most since 2007
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LZA
73in 2025
MAUDE reports naming product code LZA, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 21 | 95 | 0 | 7 |
| 2008 | 18 | 97 | 0 | 2 |
| 2009 | 28 | 112 | 0 | 12 |
| 2010 | 31 | 97 | 0 | 12 |
| 2011 | 26 | 122 | 0 | 9 |
| 2012 | 33 | 110 | 0 | 11 |
| 2013 | 20 | 130 | 0 | 10 |
| 2014 | 27 | 197 | 0 | 8 |
| 2015 | 20 | 112 | 1 | 12 |
| 2016 | 30 | 171 | 1 | 25 |
| 2017 | 44 | 124 | 0 | 4 |
| 2018 | 22 | 178 | 0 | 3 |
| 2019 | 25 | 212 | 0 | 21 |
| 2020 | 30 | 101 | 0 | 4 |
| 2021 | 139 | 111 | 0 | 20 |
| 2022 | 146 | 111 | 0 | 19 |
| 2023 | 62 | 92 | 0 | 24 |
| 2024 | 30 | 89 | 0 | 76 |
| 2025 | 24 | 110 | 0 | 73 |
| 2026 | 15 | 103 | 3 | — |
What is it indicated for?
A patient examination glove is a disposable device intended for medical purpose that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. These gloves were tested for use with Chemotherapy Drugs and Fentanyl Citrate as per ASTM D6978-05 (2019). The following chemicals have been tested with these gloves. S.No Chemotherapy Drugs Concentration Minimum Breakthrough Detection Time (Specimen 1,2,3) (Minutes) 1…
Read the full statement (232 words)
A patient examination glove is a disposable device intended for medical purpose that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. These gloves were tested for use with Chemotherapy Drugs and Fentanyl Citrate as per ASTM D6978-05 (2019).
The following chemicals have been tested with these gloves.
S.No Chemotherapy Drugs Concentration Minimum Breakthrough
Detection Time
(Specimen 1,2,3)
(Minutes)
1 Carboplatin, 10 mg/ml (10,000 ppm) >240 min.
2 Carmustine, 3.3 mg/ml (3,300 ppm) 26.6 (27.5,26.6,26.8)
3 Cisplatin, 1 mg/ml (1,000 ppm) >240 min.
4 Cyclophosphamide, 20 mg/ml (20,000 ppm) >240 min.
5 Dacarbazine, 10 mg/ml (10,000 ppm) >240 min.
6 Doxorubicin HCI, 2 mg/ml (2,000 ppm) >240 min.
7 Etoposide, 20 mg/ml (20,000 ppm) >240 min.
8 Fluorouracil, 50 mg/ml (50,000 ppm) >240 min.
9 Methotrexate, 25 mg/ml (25,000 ppm) >240 min.
10 Mitomycin C, 0.5 mg/ml (500 ppm) >240 min.
11 Mitoxantrone, 2 mg/ml (2,000 ppm) >240 min.
12 Oxaliplatin, 5 mg/ml (5,000 ppm) >240 min.
13 Paclitaxel, 6 mg/ml (6,000 ppm) >240 min.
14 Thiotepa, 10 mg/ml (10,000 ppm) 56.0 (58.4,56.5,56.0)
15 Vincristine Sulfate, 1 mg/ml (1,000 ppm) >240 min.
S.No Opiod Drugs Concentration Minimum Breakthrough
Detection Time
(Specimen 1,2,3)
(Minutes)
16 Fentanyl Citrate Injection 100mcg/2mL >240 min.
Please note that the following drugs have low permeation times:
Carmustine: 26.6 minutes
Thiotepa: 56.0 minutes
Warning - Please do not use with Carmustine and Thiotepa
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K222181 · printed Nov 6, 2026
Cite this page
510(k) Report. “K222181: Iconic Blue Nitrile Glove - Tested for use with Chemotherapy Drugs & Fentanyl Citrate.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K222181
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026